-The Indian Express A little over 11 years ago, when the Congress defeated the Asom Gana Parishad and Tarun Gogoi took over as chief minister of Assam, people had their doubts. Would this man who had spent most of his political career since 1971 as a Lok Sabha member be able to run this state? The state, with its unique tangle of ethnicity and politics, has, after all, always been a...

-The Hindu Interim ban on tourism activities in reserves will continue Even as it extended its interim order banning tourist activities in the core areas of tiger reserves, the Supreme Court on Wednesday pulled up the Centre for inaction on protecting the tiger population. A Bench of Justices A.K. Patnaik and Swatanter Kumar extended the ban when Wasim A. Qadri, counsel for the National Tiger Conservation Authority (NTCA) under the Ministry of Environment...

-The Hindu Newspaper establishments in insurgency-afflicted Manipur resemble war offices, with heavily armed police guarding them. In addition to the State forces, the managements have engaged on a permanent basis private security men to guard the main gates and the offices. Editors and high profile journalists are avoiding public appearances and almost all of them have changed their mobile numbers clandestinely. They talk over telephone only when the caller’s identity is...

-The Hindu The debate on the pros and cons of genetically engineered/modified crops is universal. In India, in the face of vociferous protests, the controversy has only deepened leading to a moratorium on cultivation of Bt Brinjal crop — the first GM food crop sought to be commercialised. Gargi Parsai spoke to Basudeb Acharia, Chairman of the Parliamentary Standing Committee on Agriculture, on its new report, “Cultivation of Genetically Modified Food...

-The Economic Times Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new drug trials.  According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...